Evolving Role of Bone Biomarkers in Castration-Resistant Prostate Cancer

by Janet E. Brown, Sheryl Sim
Published 2010-09-01

Personal Medicine and Bone Metastases: Biomarkers, Micro-RNAs and Bone Metastases

by Steven L. Wood, Janet E. Brown
Published 2020-07-01

Dedicator of Cytokinesis 4: A Potential Prognostic and Predictive Biomarker Within the Metastatic Spread of Breast Cancer to Bone

by Janet E Brown, Jules A Westbrook, Steven L Wood
Published 2019-08-01

Myeloma Bone Disease: The Osteoblast in the Spotlight

by Rebecca E. Andrews, Janet E. Brown, Michelle A. Lawson, Andrew D. Chantry
Published 2021-09-01

Complications of bone metastases from malignant melanoma

by Jamal Zekri, Maria Marples, Dominic Taylor, Kiran Kandukurti, Lucy McParland, Janet E. Brown
Published 2017-09-01

Feasibility Study on Using Dynamic Contrast Enhanced MRI to Assess the Effect of Tyrosine Kinase Inhibitor Therapy within the STAR Trial of Metastatic Renal Cell Cancer

by Jim Zhong, Ebrahim Palkhi, David L. Buckley, Fiona J. Collinson, Christy Ralph, Satinder Jagdev, Naveen S. Vasudev, Jayne Swain, Janet E. Brown, Tze Min Wah
Published 2021-07-01

Guidance for the assessment and management of prostate cancer treatment-induced bone loss. A consensus position statement from an expert group

by Janet E. Brown, Catherine Handforth, Juliet E. Compston, William Cross, Nigel Parr, Peter Selby, Steven Wood, Lawrence Drudge-Coates, Jennifer S. Walsh, Caroline Mitchell, Fiona J. Collinson, Robert E. Coleman, Nicholas James, Roger Francis, David M. Reid, Eugene McCloskey
Published 2020-12-01